For example, RAD51 recombinase ( RAD51 ) and Breast cancer type 1 ( BRCA1 ), genes involved in double-stranded break homologous recombination, are linked to the development of ovarian and breast cancers [27,28] and are also downregulated in uterine fibroids [29]
Ongoing cellular protection
Scenario 2 (delayed or limited approval): If cardiovascular safety concerns emerge (glucagon agonism theoretically increases heart rate and may elevate blood pressure in susceptible individuals) or gastrointestinal tolerability limits real-world adherence, retatrutide remains investigational
Then the drug would be tested for side effects in more animal models before making the jump to human trials
Honestly, there are compelling arguments on both sides, and the 'right' answer often depends on the specific protocol and research objectives
Significance of low-carbohydrate diets and fasting in patients with cancer